530 related articles for article (PubMed ID: 27977766)
21. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
[TBL] [Abstract][Full Text] [Related]
22. A positive feedback loop of lncRNA-RMRP/ZNRF3 axis and Wnt/β-catenin signaling regulates the progression and temozolomide resistance in glioma.
Liu T; Hu J; Han B; Tan S; Jia W; Xin Y
Cell Death Dis; 2021 Oct; 12(11):952. PubMed ID: 34657141
[TBL] [Abstract][Full Text] [Related]
23. Highly expressed long non-coding RNA NNT-AS1 promotes cell proliferation and invasion through Wnt/β-catenin signaling pathway in cervical cancer.
Hua F; Liu S; Zhu L; Ma N; Jiang S; Yang J
Biomed Pharmacother; 2017 Aug; 92():1128-1134. PubMed ID: 28628975
[TBL] [Abstract][Full Text] [Related]
24. Elevated CRB3 expression suppresses breast cancer stemness by inhibiting β-catenin signalling to restore tamoxifen sensitivity.
Li P; Feng C; Chen H; Jiang Y; Cao F; Liu J; Liu P
J Cell Mol Med; 2018 Jul; 22(7):3423-3433. PubMed ID: 29602199
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma.
Zeng XC; Liu FQ; Yan R; Yi HM; Zhang T; Wang GY; Li Y; Jiang N
Mol Cancer; 2014 Dec; 13():261. PubMed ID: 25491321
[TBL] [Abstract][Full Text] [Related]
26. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
27. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
28. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway.
Wang F; Ying HQ; He BS; Pan YQ; Deng QW; Sun HL; Chen J; Liu X; Wang SK
Oncotarget; 2015 Apr; 6(10):7899-917. PubMed ID: 25760077
[TBL] [Abstract][Full Text] [Related]
29. Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer.
Peng WX; Huang JG; Yang L; Gong AH; Mo YY
Mol Cancer; 2017 Oct; 16(1):161. PubMed ID: 29041978
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of β-Catenin to Overcome Endocrine Resistance in Tamoxifen-Resistant Breast Cancer Cell Line.
Won HS; Lee KM; Oh JE; Nam EM; Lee KE
PLoS One; 2016; 11(5):e0155983. PubMed ID: 27196739
[TBL] [Abstract][Full Text] [Related]
31. RTKN2 knockdown alleviates the malignancy of breast cancer cells by regulating the Wnt/β-catenin pathway.
Zhang X; Wang J; Li H
Sci Rep; 2023 Dec; 13(1):23023. PubMed ID: 38155217
[TBL] [Abstract][Full Text] [Related]
32. Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway.
Zhang ZM; Wu JF; Luo QC; Liu QF; Wu QW; Ye GD; She HQ; Li BA
Oncogene; 2016 Sep; 35(36):4787-97. PubMed ID: 26876203
[TBL] [Abstract][Full Text] [Related]
33. H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b/WNT/β-catenin in ox-LDL -stimulated vascular smooth muscle cells.
Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
J Biomed Sci; 2018 Feb; 25(1):11. PubMed ID: 29415742
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer.
Cheng N; Cai W; Ren S; Li X; Wang Q; Pan H; Zhao M; Li J; Zhang Y; Zhao C; Chen X; Fei K; Zhou C; Hirsch FR
Oncotarget; 2015 Sep; 6(27):23582-93. PubMed ID: 26160838
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR-143.
Tuo YL; Li XM; Luo J
Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3403-11. PubMed ID: 26439035
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
Xia S; Ji R; Zhan W
BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
[TBL] [Abstract][Full Text] [Related]
37. Long Non-Coding RNA (LncRNA) Urothelial Carcinoma Associated 1 (UCA1) Increases Multi-Drug Resistance of Gastric Cancer via Downregulating miR-27b.
Fang Q; Chen X; Zhi X
Med Sci Monit; 2016 Oct; 22():3506-3513. PubMed ID: 27694794
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer.
Tan Z; Zheng H; Liu X; Zhang W; Zhu J; Wu G; Cao L; Song J; Wu S; Song L; Li J
Oncotarget; 2016 Apr; 7(17):24076-87. PubMed ID: 26992223
[TBL] [Abstract][Full Text] [Related]
39. SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β-catenin pathway via CTNNB1.
Chen M; Li L; Zheng PS
Cancer Sci; 2019 Sep; 110(9):2794-2805. PubMed ID: 31336010
[TBL] [Abstract][Full Text] [Related]
40. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
